Spinal & Smart Device Markets Surge
Analysts project rapid growth in the corpectomy systems market through 2033 — with Medtronic, DePuy Synthes, Stryker and NuVasive named as major players — while the global smart medical devices market is forecast to reach about $180.38 billion by 2033 at a 12.8% CAGR, reported reported. Both trends point to durable demand in surgical implants and connected devices.
Independent research houses place the corpectomy-systems market at roughly $1.27 billion in 2024 with a projection to $2.40 billion by 2034 (≈5.3% CAGR in that model) emergenresearch.com, while a separate analysis pegged 2023 revenue at $1.29 billion and forecast growth to $2.14 billion by 2032 (≈5.6% CAGR), highlighting variation in segment definitions and forecast horizons across vendors. analytica.global Medtech incumbents are refreshing corpectomy portfolios: Medtronic markets the T2 Altitude expandable corpectomy system and AsterX expandable cervical solutions for anterior corpectomy approaches medtronic.com, and NuVasive’s X‑CORE/Monolith vertebral‑body replacement products remain listed with regulatory clearances amid the company’s integration into Globus following the $3.1 billion merger completed in September 2023. catablog.com Competitive dynamics shifted in 2024–2025 as Stryker agreed to and completed the sale of its U.S. spinal‑implants business to Viscogliosi Brothers to form VB Spine—transferring roughly $700 million of 2024 implant sales and reshaping mid‑market implant competition investors.stryker.com; Johnson & Johnson’s DePuy Synthes pushed into surgical systems with the VELYS active spine robotic/navigation platform cleared and launched in August 2024 to pair navigation with its implant portfolio. jnj.com Market research on connected devices shows rapid adoption within smart medical devices: one report recorded a year‑over‑year rise from about $55.1 billion (2023) to $61.7 billion (2024) and flagged therapeutic devices as the largest product segment and North America as the largest regional share, naming Abbott, Medtronic, Roche, Philips, Dexcom, Masimo, Apple, Samsung and GE Healthcare among top vendors. datamintelligence.com Device OEMs are coupling implants with remote care products—Medtronic’s CareLink/MCMS remote‑monitoring platforms and a strategic collaboration with FluidAI for post‑surgical at‑home monitoring illustrate integration trends medtronic.com, and regulatory moves such as the recent FDA action on Abbott’s updated CardioMEMS reader underline ongoing product refreshes that ease home use for implant‑linked monitoring. medtechdive.com
